JPMorgan Weighs Fed Capital Funding Formula, Warning on $13B Relief
JPMorgan Chase traded at $353 as a regulatory fight over how the Federal Reserve treats short-term wholesale funding could cut $13 billion of potential capital relief. A June comment letter indicates the Fed’s capital overhaul would reduce expected benefits by changing measurements used for G-SIB surcharges, with the bank arguing the formula favors trading-heavy rivals while supporters say it better reflects risk.